Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea

NCT03263273 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

270

Enrollment

INDUSTRY

Sponsor class

Conditions

Rosacea
Papulopustular Rosacea

Interventions

DRUG: 1% Topical Minocycline Gel
DRUG: 3% Topical Minocycline Gel
OTHER: Topical Vehicle Gel

Sponsor

Hovione Scientia Limited